Table 5 Patient characteristics of the six cases with microrosatellite instability (MSI).
| MSI‐high | MSI‐high | MSI‐low | MSI‐low | LOH | LOH | |
|---|---|---|---|---|---|---|
| Age (years) | 68 | 51 | 36 | 47 | 39 | 35 |
| Follow‐up (years) | 10.2 | 6.9 | 10.1 | 6.4 | 9.6 | 8.3 |
| FIGO stage | IIA | IB1 | IIA | IB1 | IB1 | IB2 |
| Histology | Squamous | Adeno | Squamous | Squamous | Squamous | Squamous |
| Grade | 2 | 3 | 3 | 2 | 2 | 3 |
| LNM | Present | Absent | Absent | Absent | Absent | Present |
| Cancer invasion | >10 mm | >10 mm | >10 mm | 5–10 mm | >10 mm | 5–10 mm |
| LVSI | Present | Present | Absent | Present | Present | Absent |
| Recurrence | Absent | Absent | Absent | Absent | Absent | Absent |
| MSH2 | Negative | Negative | Positive | Positive | Negative | Negative |
| MSI/LOH locus | D5S346 | BAT25 | D17S250 | D17S250 | D17S250 | D17S250 |
| D17S250 | BAT26 |
FIGO, International Federation of Gynecology and Obstetrics; LNM, lymph node metastasis; LOH, loss of heterozygosity; LVSI, lymph vascular space involvement.